arginine and Oligodendroglioma

arginine has been researched along with Oligodendroglioma in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balss, J; Capper, D; Hartmann, C; von Deimling, A; Zentgraf, H1
Reitman, ZJ; Yan, H1
Essig, M; Hartmann, C; Mawrin, C; Meyer, J; Schmieder, K; Seiz, M; Tuettenberg, J; von Deimling, A1
Bremer, J; Capper, D; Harter, PN; Hartmann, C; Jeibmann, A; Reuss, D; Sahm, F; Schittenhelm, J; von Deimling, A1
Basso, U; Brandes, AA; Ermani, M; Jirillo, A; Koussis, H; Lonardi, S; Monfardini, S; Paris, MK; Pasetto, LM; Tosoni, A; Vastola, F1
Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M1
Di Stefano, E; Gerosa, MA; Olivi, A1
Addison, D; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Maroun, JA; Peterson, E; Richard, MT; Russell, N; Stewart, DJ1
Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O1

Reviews

1 review(s) available for arginine and Oligodendroglioma

ArticleYear
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
    Journal of the National Cancer Institute, 2010, Jul-07, Volume: 102, Issue:13

    Topics: Animals; Arginine; Brain Neoplasms; Codon; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Glucose; Glutarates; Humans; Hypoxia; Isocitrate Dehydrogenase; Mutation; NADP; Neoplasms; Oligodendroglioma; Oncogenes; Signal Transduction; Up-Regulation

2010

Trials

2 trial(s) available for arginine and Oligodendroglioma

ArticleYear
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome

2003
Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary
    Neurosurgery, 1984, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Carotid Arteries; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Ependymoma; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Oligodendroglioma; Teniposide; Tomography, X-Ray Computed

1984

Other Studies

7 other study(ies) available for arginine and Oligodendroglioma

ArticleYear
Monoclonal antibody specific for IDH1 R132H mutation.
    Acta neuropathologica, 2009, Volume: 118, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Arginine; Astrocytoma; Brain Neoplasms; Histidine; Humans; Isocitrate Dehydrogenase; Mice; Mutant Proteins; Mutation; Oligodendroglioma; Sensitivity and Specificity

2009
Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Acta neuropathologica, 2010, Volume: 120, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; DNA Mutational Analysis; Female; Histidine; Humans; In Situ Hybridization, Fluorescence; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neoplasms, Neuroepithelial; Oligodendroglioma; Polymorphism, Single Nucleotide; Tumor Suppressor Protein p53

2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Acta neuropathologica, 2011, Volume: 121, Issue:2

    Topics: Adolescent; Adult; Aged; Antibodies; Arginine; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Glioma; Histidine; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Nerve Tissue Proteins; Oligodendroglioma; Young Adult

2011
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
    Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine

2015
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    BMC cancer, 2006, Oct-18, Volume: 6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome

2006
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
    Surgical neurology, 1981, Volume: 15, Issue:2

    Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide

1981
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide

1997